Save for later

Continued disruption to supply of Apidra (insulin glulisine)

Sanofi have informed us of a continued interruption to the supply of Apidra (insulin glulisine) OPTISET and SOLOSTAR prefilled pens and CLIKSTAR reusable cartridges, following a production problem at their factory. They now anticipate a return to stock in March 2012, which is longer than the anticipated date of December 2011 given when we first reported the problem.

None of the other Sanofi insulin products (Lantus, Insuman) have been affected. Supplies of Apidra insulin vials continue to be available.

What should you do?

To help make sure that as many patients as possible can obtain the medicines they need, please don’t ask your doctor or nurse for a new prescription of Apidra until you are reaching the end of your supply.

When you have a prescription, take this to the pharmacy as you usually do. For small number of patients (including children) apidra may be the only insulin that is suitable. A supply of apidra has been reserved on a case-by-case basis which your pharmacist will do everything they can to fulfill the prescription.

In some cases this may not be possible. If this happens, your pharmacist will speak to your doctor to let them know that your usual insulin is not available. Your doctor or nurse will then look at what other insulin may be suitable for you as a temporary measure until Apidra is available again. Your pharmacist might be able to supply this after speaking with the doctor, or they might ask you to go back to see your doctor before a choice is made.

Where can you get more information?

Sanofi has a 24 hour-a-day Patient Support Line. The Support Line will be able to help with your questions, and will have up-to-date information as to when Apidra will be available again.

The phone number for the Patient Support Line is 0845 606 6887. Your doctor, nurse or pharmacist will be able to help you if you still have questions about your care or your medicines.

Brand Icons/Telephone check - FontAwesome icons/tick icons/uk